Kaleido Biosciences Profitability Analysis

KLDO -  USA Stock  

USD 5.69  0.03  0.52%

For Kaleido Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Kaleido Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Kaleido Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Kaleido Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Kaleido Biosciences over time as well as its relative position and ranking within its peers. Please see Stocks Correlation.

Search Current Profitability Trends 

The value of Price to Sales Ratio is estimated to slide to 279.34. The value of Return on Sales is estimated to slide to -78.5. The value of Consolidated Income is estimated to slide to about (88.1 M). The value of Net Income is estimated to slide to about (88.1 M).
The market value of Kaleido Biosciences is measured differently than its book value, which is the value of Kaleido that is recorded on the company's balance sheet. Investors also form their own opinion of Kaleido Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Kaleido Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kaleido Biosciences' market value can be influenced by many factors that don't directly affect Kaleido Biosciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kaleido Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Kaleido Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kaleido Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Kaleido Biosciences Return On Equity vs. Cash per Share Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Kaleido Biosciences's current stock value. Our valuation model uses many indicators to compare Kaleido Biosciences value to that of its competitors to determine the firm's financial worth.
Kaleido Biosciences is rated below average in cash per share category among related companies. It is rated below average in return on equity category among related companies . . Average Equity is expected to rise to about 38.1 M this year

Kaleido Return On Equity vs. Cash per Share

Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Kaleido Biosciences 
Cash per Share 
Total Cash 
Average Shares 
2.17 X
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Kaleido Biosciences 
Return on Equity 
Net Income 
Total Equity 
(161.51) %
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

Kaleido Return On Equity Comparison

Kaleido Biosciences is currently under evaluation in return on equity category among related companies.

Kaleido Biosciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Kaleido Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Kaleido Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Kaleido Biosciences' change in net profit over the period of time. It can combine multiple indicators of Kaleido Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for 2021
Consolidated Income-81.6 M-88.1 M
Net Income-81.6 M-88.1 M
Net Income Common Stock-81.6 M-88.1 M
Operating Income-78.9 M-85.1 M
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts. Kaleido Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 82 people.

Kaleido Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Kaleido Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Kaleido Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Kaleido Biosciences' important profitability drivers and their relationship over time.

Kaleido Biosciences Profitability Trends

Kaleido Biosciences profitability trend refers to the progression of profit or loss within a business. An upward trend means that Kaleido Biosciences' profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is Kaleido Biosciences' gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.

Kaleido Biosciences Profitability Drivers Correlations

One of the toughest challenges investors face today is learning how to quickly synthesize and read into endless financial statements and information provided by the company, SEC reporting, and various external parties. Understanding the correlation between Kaleido Biosciences different financial indicators related to revenue and profit generation helps investors identify and prioritize their investing strategies towards Kaleido Biosciences in a much-optimized way. Analyzing correlations between profit drivers that are directly associated with dollar figures is the most effective way to break down Kaleido Biosciences' future profitability.

Use Kaleido Biosciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kaleido Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kaleido Biosciences will appreciate offsetting losses from the drop in the long position's value.

Kaleido Biosciences Pair Trading

Kaleido Biosciences Pair Trading Analysis

Correlation analysis and pair trading evaluation for Kaleido Biosciences and Equillium. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Use Investing Themes to Complement your Kaleido Biosciences position

In addition to having Kaleido Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run World Allocation Thematic Idea Now

World Allocation
World Allocation Theme
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. World Allocation theme has 40 constituents.
View All  Next Launch World Allocation
Please see Stocks Correlation. Note that the Kaleido Biosciences information on this page should be used as a complementary analysis to other Kaleido Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Kaleido Stock analysis

When running Kaleido Biosciences price analysis, check to measure Kaleido Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kaleido Biosciences is operating at the current time. Most of Kaleido Biosciences' value examination focuses on studying past and present price action to predict the probability of Kaleido Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kaleido Biosciences' price. Additionally, you may evaluate how the addition of Kaleido Biosciences to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Valuation
Check real value of public entities based on technical and fundamental data
To fully project Kaleido Biosciences' future profitability" href="/future-stock-price/KLDO">future profitability, investors should examine all historical financial statements" href="/financial-statements/KLDO">financial statements. These statements provide investors with a comprehensive snapshot of the financial position" href="/financial-statements/KLDO">financial position of Kaleido Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements" href="/financial-statements/KLDO">financial statements. These documents include Kaleido Biosciences' income statement, its balance sheet, and the statement of cash flows.
Potential Kaleido Biosciences investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Kaleido Biosciences investors may work on each financial statement separately, they are all related. The changes in Kaleido Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Kaleido Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.